Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 5751-5800 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT07000682
The Clinical Study on the Treatment of SSc With UTAA91 Injection.
EARLY_PHASE1Recruiting
24 participants
Started: May 30, 2025 · Completed: Jan 31, 2040
1 condition1 sponsor1 location
NCT06983366
Validation and Clinical Utility of the Lung Sliding Index (LSI) for Differentiating Pulmonary Diseases
N/ARecruiting
700 participants
Started: May 30, 2025 · Completed: Mar 1, 2026
7 conditions2 sponsors1 location
NCT07001956
The Clinical Study on the Treatment of Refractory RA With UTAA91 Injection
EARLY_PHASE1Recruiting
24 participants
Started: May 30, 2025 · Completed: Jun 30, 2040
1 condition1 sponsor1 location
NCT06941610
An Evaluation of the Erchonia Laser As a Non-Invasive Treatment to Improve the Appearance of Skin Laxity
NARecruiting
35 participants
Started: May 30, 2025 · Completed: Nov 1, 2026
1 condition1 sponsor1 location
NCT06872905
Real-World Data Collection of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis When Used in Covered Endovascular Reconstruction of the Aortic Bifurcation (CERAB) to Treat Aortoiliac Occlusive Disease
N/ARecruiting
158 participants
Started: May 30, 2025 · Completed: Aug 16, 2027
1 condition1 sponsor8 locations
NCT06868836
A Study of JS207 (PD-1/VEGF Bispecific Antibody) in Combination With Chemotherapy in Advanced Non-small Cell Lung Cancer
PHASE2Recruiting
42 participants
Started: May 30, 2025 · Completed: Apr 30, 2027
1 condition1 sponsor1 location
NCT07031349
MARPE-Associated Changes in Sleep and Airway
NARecruiting
40 participants
Started: May 30, 2025 · Completed: Sep 5, 2025
1 condition1 sponsor1 location
NCT07041476
HYBRID TELE-REHABILITATION VERSUS CLINIC-BASED THERAPY IN PATIENTS WITH LUMBAR RADICULOPATHY: A RANDOMIZED CONTROLLED TRIAL
NARecruiting
32 participants
Started: May 30, 2025 · Completed: Sep 30, 2025
1 condition1 sponsor1 location
NCT06980155
XP-005 Personalized Vaccine Alone or in Combination With Toripalimab for the Prevention of Relapse After Remission in Acute Myeloid Leukemia
EARLY_PHASE1Recruiting
60 participants
Started: May 30, 2025 · Completed: Aug 30, 2028
1 condition2 sponsors1 location
NCT06993974
Nitazoxanide in Patients With Ulcerative Colitis
PHASE2Recruiting
70 participants
Started: May 30, 2025 · Completed: Dec 20, 2026
1 condition4 sponsors1 location
NCT07087873
Assessment of Transcranial Alternating Current Stimulation's Clinical Efficacy in Treating Cognitive Impairment of Idiopathic Inflammatory Demyelinating Diseases
NARecruiting
128 participants
Started: May 30, 2025 · Completed: Oct 31, 2027
5 conditions1 sponsor1 location
NCT06940960
JY231(JY231) Injection for the Treatment of Relapsed/Refractory B Cell Lymphoma/ Leukemia
NARecruiting
20 participants
Started: May 30, 2025 · Completed: Dec 31, 2027
2 conditions1 sponsor1 location
NCT07124091
The Effect of a Micro-Appreciation Intervention (Three-Things Journal Application) on Caregiver Burden, Family Functioning, and Happiness Levels for Mothers of Children With Autism Spectrum Disorder
NARecruiting
126 participants
Started: May 30, 2025 · Completed: Aug 30, 2025
2 conditions1 sponsor1 location
NCT06124157
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
PHASE3Recruiting
222 participants
Started: May 30, 2025 · Completed: Dec 1, 2030
1 condition1 sponsor83 locations
NCT07011862
COBRA: Cancer, Older Adults, Balance and Resistance Activities
NARecruiting
38 participants
Started: May 30, 2025 · Completed: May 30, 2027
3 conditions1 sponsor6 locations
NCT06927973
Leveraging Exercise Stress Echocardiography for Heart Failure With Preserved Ejection Fraction
NARecruiting
30 participants
Started: May 30, 2025 · Completed: Jan 31, 2026
2 conditions1 sponsor1 location
NCT07210099
The Effect of Short-term Supplementation of OliPhenolia® on Fat Oxidation.
NARecruiting
40 participants
Started: May 30, 2025 · Completed: Mar 30, 2026
1 condition1 sponsor1 location
NCT06476938
Testing Gene PilotLX With Latinx Cancer Patients
NARecruiting
232 participants
Started: May 30, 2025 · Completed: Dec 31, 2027
1 condition6 sponsors4 locations
NCT06947499
A Phase II/III Study to Evaluate the Immunogenicity, Safety and Lot-to-lot Consistency of LBVD, a Fully Liquid Hexavalent Diphtheria-tetanus-whole Cell Pertussis-hepatitis B-poliovirus-Haemophilus Influenzae Type b Conjugate (DTwP-HepB-IPV-Hib) Vaccine, in Healthy Infants as Primary Series
PHASE2/PHASE3Recruiting
1,186 participants
Started: May 30, 2025 · Completed: Apr 30, 2027
6 conditions1 sponsor1 location
NCT06994689
Clinimetric Properties of Muscle Mass and Stiffness Measurements of the Quadriceps in Patients With COPD
N/ARecruiting
30 participants
Started: May 30, 2025 · Completed: Dec 1, 2026
2 conditions1 sponsor1 location
NCT07011004
A Study of Natural Killer Cells in Combination With Atezolizumab in People With Acute Myelogenous Leukemia
PHASE1Recruiting
18 participants
Started: May 30, 2025 · Completed: May 31, 2028
2 conditions2 sponsors7 locations
NCT07000604
Effect of ınhaler Use on Oral Health in COPD Patients
NARecruiting
80 participants
Started: May 30, 2025 · Completed: Oct 30, 2025
1 condition1 sponsor1 location
NCT06821945
A Clinical Trial to Evaluate the Safety and Efficacy of Olanzapine Titration Schedule in Patients With Schizophrenia
PHASE2Recruiting
120 participants
Started: May 30, 2025 · Completed: May 31, 2027
1 condition1 sponsor2 locations
NCT06790966
Phase 3 Study of PDS0101 and Pembrolizumab in HPV16+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
PHASE3Recruiting
351 participants
Started: May 30, 2025 · Completed: Feb 28, 2029
5 conditions1 sponsor21 locations
NCT06974253
Morphological Characteristics of Anterior Maxillary Bone and Dynamic Navigation in Full-Arch Implant Placement
NARecruiting
20 participants
Started: May 30, 2025 · Completed: Feb 29, 2028
2 conditions1 sponsor1 location
NCT06961565
PAS-004 in Adults Who Have Neurofibromatosis Type 1 With Plexiform Neurofibromas
PHASE1Recruiting
56 participants
Started: May 30, 2025 · Completed: Dec 31, 2027
5 conditions2 sponsors4 locations
NCT06640192
Administration of High Doses of Antiretroviral Drugs to Eliminate the Latent HIV-1 Reservoir
PHASE2Recruiting
24 participants
Started: May 30, 2025 · Completed: Jan 31, 2027
1 condition1 sponsor2 locations
NCT07036900
Effects of Flexion and Extension Type Arm Slings on Walking Kinematics and Balance in Stroke Patients
N/ARecruiting
48 participants
Started: May 30, 2025 · Completed: Apr 30, 2026
1 condition1 sponsor1 location
NCT06969430
A Study to Assess the Safety, Tolerability, and Antileukemic Activity of Debio 1562M in Participants With Acute Myeloid Leukemia (AML)
PHASE1/PHASE2Recruiting
134 participants
Started: May 30, 2025 · Completed: Nov 30, 2031
1 condition1 sponsor7 locations
NCT06975059
Novel Shoe Device NUSHU to Measure Gait Analysis in Parkinson's Patients
NARecruiting
40 participants
Started: May 30, 2025 · Completed: Jul 31, 2030
1 condition1 sponsor1 location
NCT06917404
A Study to Investigate the Treatment Effect of Subcutaneous Injections of Pentosan Polysulfate Sodium Compared With Placebo in Adult Participants With Knee Osteoarthritis Pain.
PHASE3Recruiting
466 participants
Started: May 29, 2025 · Completed: Jul 31, 2027
1 condition1 sponsor3 locations
NCT06844487
Phase 3 Infant Safety & Immunogenicity Trial of MVA-BN® in DRC
PHASE3Recruiting
344 participants
Started: May 29, 2025 · Completed: Nov 30, 2026
6 conditions7 sponsors1 location
NCT06833463
Tacrolimus and Risk Factors for Glucose Metabolism Disorders in Kidney Transplant Patients
N/ARecruiting
120 participants
Started: May 29, 2025 · Completed: Jan 30, 2028
1 condition1 sponsor6 locations
NCT06729996
Pioglitazone Versus Empagliflozin for Chronic Pancreatitis/Recurrent Acute Pancreatitis Associated Diabetes Mellitus
PHASE2Recruiting
40 participants
Started: May 29, 2025 · Completed: May 31, 2027
3 conditions2 sponsors2 locations
NCT07004296
A Study of HDM2005 in Patients With Advanced Solid Tumor
PHASE1Recruiting
72 participants
Started: May 29, 2025 · Completed: Dec 1, 2027
1 condition1 sponsor1 location
NCT06821841
Pilot Trial of an Online Physical Activity Intervention for Peri- and Post-menopausal Working Women
NARecruiting
24 participants
Started: May 29, 2025 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT06751537
Effectiveness of the WearME System for COPD Severity and Respiratory Function
N/ARecruiting
128 participants
Started: May 29, 2025 · Completed: Feb 28, 2026
1 condition6 sponsors2 locations
NCT07001319
Study of GS-3242 in Participants With HIV-1
PHASE1Recruiting
30 participants
Started: May 29, 2025 · Completed: Feb 28, 2027
1 condition1 sponsor18 locations
NCT05848037
Assessment of CymActive™ Catheter Technology for UrinAry ReTention and AcceptancE (The ACCTUATE Study)
NARecruiting
60 participants
Started: May 29, 2025 · Completed: Dec 30, 2025
1 condition1 sponsor5 locations
NCT06908096
Epstein-Barr Virus (EBV) gH/gL/gp42-Ferritin Nanoparticle Vaccine With or Without gp350-Ferritin in Healthy Adults With or Without EBV Infection
PHASE1Recruiting
750 participants
Started: May 29, 2025 · Completed: Oct 1, 2028
4 conditions1 sponsor1 location
NCT06904872
Safety and Efficacy of Crofelemer in Adult Patients With Short Bowel Syndrome and Intestinal Failure (SBS-IF) Without Colon-in-continuity (CIC)
PHASE2Recruiting
18 participants
Started: May 29, 2025 · Completed: Feb 28, 2026
5 conditions1 sponsor8 locations
NCT07006077
Recombinant Human IL-21-expressing Oncolytic Vaccinia Virus Injection (hV01) in Advanced Pancreatic Cancer
PHASE2Recruiting
12 participants
Started: May 29, 2025 · Completed: Jun 5, 2026
1 condition1 sponsor1 location
NCT06795035
Assessment of Coronary Microvascular Dysfunction After STEMI Using Continuous Saline Thermodilution
N/ARecruiting
70 participants
Started: May 29, 2025 · Completed: Dec 31, 2027
3 conditions2 sponsors1 location
NCT06574373
Identification of New Theranostic Biomarkers of Pancreatic Tumor Progression
N/ARecruiting
3,600 participants
Started: May 29, 2025 · Completed: Dec 31, 2026
1 condition4 sponsors2 locations
NCT07152288
Investigation of Pharmacokinetics,Safety,and Pharmacodynamics of HSK39297 in Subjects With Hepatic Impairment
PHASE1Recruiting
24 participants
Started: May 29, 2025 · Completed: Nov 30, 2025
1 condition1 sponsor1 location
NCT06533644
A Study of SYNC-T Therapy SV-102 in Participants With Metastatic Castration-Resistant Prostate Cancer
PHASE2Recruiting
70 participants
Started: May 29, 2025 · Completed: Dec 14, 2027
1 condition1 sponsor5 locations
NCT07020923
Monthly Dosing of Atacicept in IgAN
PHASE2Recruiting
90 participants
Started: May 29, 2025 · Completed: Sep 30, 2027
2 conditions1 sponsor1 location
NCT06604858
Neoadjuvant Pembrolizumab and Carboplatin Plus Paclitaxel for Stage I Triple-negative Breast Cancer
PHASE2Recruiting
30 participants
Started: May 29, 2025 · Completed: Oct 31, 2026
2 conditions2 sponsors11 locations
NCT06969274
Ultrasound-guided Sacral Erector Spinae Plane Block as a Sole Anesthetic Technique Versus Saddle Block in Hemorrhoidectomy
NARecruiting
50 participants
Started: May 29, 2025 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT07021820
Multispectral Optoacoustic Tomography for Advanced Imaging of Centronuclear Myopathy
N/ARecruiting
40 participants
Started: May 29, 2025 · Completed: Dec 31, 2026
1 condition1 sponsor1 location